Delivery Order SPE2DB24D1021-SPE2DB25FFBBH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $61,937.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,533.10 to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count units) on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in military and veteran healthcare systems for cardiovascular...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $3,226.05 to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in military and veteran healthcare systems for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Brilinta 90 mg tablets (60-count packaging) with a ceiling value of $7,397.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets in a quantity of 60-count units. This contract was competitively awarded without a set-aside designation and carries a ceiling value of $1,708.26 under firm fixed-price terms. The delivery order was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Brilinta 60 mg tablets (60 count) valued at $1,109.68. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is due for completion by August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication...
- The Defense Logistics Agency awarded a delivery order valued at $2,350.29 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on April 25, 2025, with completion scheduled for April 28, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBBHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $32,625.18 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in cardiovascular treatment, reflecting DLA's ongoing procurement of critical pharmaceutical products to support military healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this expansive contract vehicle, which enables the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.6k | 9/23/25 |